Serotype 1 and 8 Pneumococci Evade Sensing by Inflammasomes in Human Lung Tissue

Diana Fatykhova1, Anne Rabes1, Christoph Machnik1

  • 1Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Plos One
|August 29, 2015
PubMed

Insights

Streptococcus pneumoniae serotype 1 evades immune detection by producing a non-haemolytic toxin, unlike other serotypes. This evasion mechanism may explain why serotype 1 causes severe invasive diseases like pneumonia and meningitis.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Streptococcus pneumoniae causes pneumonia, sepsis, and meningitis.
  • Pneumolysin, a toxin from S. pneumoniae, is sensed by the NLRP3 inflammasome.
  • Serotype 1 strains (MLST306) are increasingly linked to invasive pneumococcal disease.

Purpose of the Study:

  • To investigate why S. pneumoniae serotype 1 causes significant invasive disease.
  • To compare inflammasome activation by different pneumococcal serotypes.
  • To elucidate the role of pneumolysin variants in immune evasion.

Main Methods:

  • Infection of human lung cells and organ cultures.
  • Measurement of inflammasome-dependent IL-1β production.
  • Analysis of pneumolysin activity from different serotypes.

Main Results:

  • Different S. pneumoniae serotypes differentially activate inflammasome-dependent IL-1β production.
  • Serotypes 2, 3, 6B, and 9N with haemolytic pneumolysins strongly activate NLRP3 inflammasome.
  • Serotype 1 and 8 strains with non-haemolytic toxins are poor activators of IL-1β.
  • Purified haemolytic pneumolysin, but not serotype 1's toxin, strongly activates IL-1β in human lungs.

Conclusions:

  • Serotype 1 pneumococci's non-haemolytic toxin may evade inflammasome-dependent innate immunity.
  • This immune evasion could contribute to the high incidence of invasive disease caused by serotype 1.
  • Understanding pneumolysin's role is crucial for combating invasive pneumococcal infections.